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INTRODUCTION: Sickle cell nephropathy (SCN) is a common complication in
patients with sickle cell disease (SCD), and the incidence of renal failure increases as
patients survival improves. Creatinine-based estimated glomerular filtration rate
(eGFR) is usually employed to assess kidney function in patients with SCD, even if its
reliability is questionable. A threshold of 30 mg/die for significant microalbuminuria
(MAU) is generally used in clinical practice. Nevertheless, children with SCD have an
increased tubular secretion of creatinine, leading to a possible underestimation of
albuminuria/creatininuria measurements; moreover, levels of MAU<30mg/die have
been associated with high risk for cardiovascular morbidity and mortality in different
populations. Early identification of renal abnormalities in patients with SCD is crucial
in order to build up strategies for prevention of progressive organ dysfunction.
METHODS:We performed an observational cohort study to assess the prevalence of
renal abnormalities and their association with clinical parameters in a population of 60
clinically stable children ofWest African descent with SCD (genotypes both HbSS and
HbSC).Wemeasured serum creatinine, serum cystatin C, MAU, proteinuria/
creatininuria (P/C), urinary NGAL and urinary osmolarity. We estimated GFR
through the following formulas: Schwartz 2009, Zappitelli cystatin C (CysC), Zappitelli
creatinine + cystatin C (crea/CysC). We divided the population in two groups, using as
a threshold the presence of MAU>10mg/g-creatinine. We compared groups for
clinically significant variables, and performed a logistic regression in order to identify
factors associated with the presence of MAU>10.
RESULTS:Mean age was 10.85 years in our population, and 60% of patients had HbSS
genotype. Forty-five percent of patients had aMAU>10, 12.73% hadMAU>30 and
5% of patients had P/C>0.3. The three formulas used to estimate GFR yielded
significantly different results in our population (mean eGFR: Schwartz 2009 144.46
4.94 ml/min, CysC 109.66 3.41 ml/min, crea/CysC 135.56 4.17; p<0.0001, ordinary
one-way ANOVA test). Patients withMAU>10 had significantly higher eGFR with
Cystatin C based formulas when compared to patients withMAU<10. A significantly
higher percentage of patients withMAU>10 carried the HbSS genotype (80%, p 0.03)
and had been treated with hydroxyurea (HU) for more than one year (76%, p 0.03).
Logistic regression identified at univariate analysis several factors associated with a
significantly higher relative risk of MAU>10: HbSS genotype (p 0.025), higher eGFR
with CysC (p 0.027) and crea/CysC (p 0.024) formulas, treatment with HU for more
than one year (p 0.03). In amultivariate analysis (adjusted for age and sex) only male
sex appeared protective forMAU>10 (RR 0.183, 95%CI 0.036, 0.933).
CONCLUSIONS:We report a high prevalence of MAU>10 (almost 50%) in a
population of SCD children; the prevalence of MAU>30 and overt proteinuria were
13% and 5% respectively in our population, in line with previous literature findings.
We encountered substantial differences between formulas used to estimate GFR,
highlighting an urgent need for comparison with measured GFR in order to definitely
establish the most suitable approximation. Patients withMAU>10 had higher eGFR
and were more likely to carry the HbSS genotype, suggesting a protective role for HbSC
genotype for SCN; also, they were more likely to have received prolonged treatment
with HU, indicating a worse disease phenotype in this subpopulation.
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INTRODUCTION: Perinatal hypoxia is an important cause of acute kidney injury
(AKI) and transient kidney impairment with adverse effects, especially during five days
after birth.
Current identification of AKI relies on acute elevation of serum creatinine (SCr), but
SCr-based definitions are hampered by numerous problems particularly in premature
infants: most important, that SCr is a measure of function, not damage. Urine
biomarkers may improve our ability to detect kidney damage.
The aim is to improve the evaluation of AKI in premature infants exposed to perinatal
hypoxia, on the basis of studying content neutrophil gelatinase - associated lipocalin
(NGAL) and interleukin-18 (IL-18) in urine.
METHODS:We have been conducted a prospective analysis of 65 premature infants
with gestational age<32 weeks (1 group), 50 children with gestational age 32 weeks
(2 group) and signs of kidney damage. The comparison group included 25 premature
newborns who were born without hypoxia and without signs of kidney damage.
Investigation of lipocalin and interleukin-18 in urine and serum creatinine was
carried out for 2-4 days of life. Excretion of interleukin-18 and lipocalin was evaluated
for IL-18/creatinine urine (pg/mg creatinine) and NGAL/creatinine urine (ng/ml
creatinine).
RESULTS: In the first days of life, SCr in children with gestational age<32 weeks was
Me 107.4 [89.4; 124.8] lmol/l, in children with gestational age 32 weeks - 98.54
[78.42; 124,36] lmol/l, which significantly exceeds the comparison group (p<0,05). At
7 days of life in preterm infants, the SCr wasMe 212.84 [159.6; 236.9] lmol/l, against
Me 66.57 [54.8; 72.6] lmol/l in comparison with children (p<0.01). In children of the
2nd group, the SCr was 3 times higher than that of the children in the comparison
groupMe 192.92 [154.7; 224.4] lmol/l (p<0.01).
The NGAL level in urine of newborns with gestational age<32 weeks was Me 96.03
[38.6; 131.23] ng/ml creatinine (defined in urine) and children with gestational age
32 weeksMe 75.10 [31.24; 126.6] ng/ml was significantly higher (in children of the
comparison groupMe 25.9 [8.24; 44.64] ng/ml creatinine), p<0.01.
IL-18 in the urine of newborns with gestational age<32 weeks and 32 weeks was
significantly higher than that of the comparison group (Me 27.98 [25.49; 29.51] pg/mg
creatinine - 1 group, Me 22.0 [19.6; 25.63] pg/mg creatinine - 2 group, and 17.41
[13.96; 18.78] pg/mg creatinine - comparison group, p<0.01).
CONCLUSIONS: Excretion of NGAL and IL-18 in urine is associated with damage of
proximal renal tubules, which prevents their reabsorption and leads to an increase in
urine concentrations. Levels of NGAL and IL-18 in the urine are diagnostic for acute
kidney damage: they grow faster than creatinine and reflect the severity of kidney
damage. Children with a gestational age of<32 weeks indicates severe damage of
kidneys due to postponed perinatal hypoxia.
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INTRODUCTION: In 2011, a major health threat of phthalate-tainted foodstuffs
which occurred in Taiwan aroused our attention for the relationship between phthalate
exposure and renal injury. The study is to elucidate whether exposure to DEHP-tainted
foods may be associated with increased risk of microalbuminuria in these children and
adolescents exposed to phthalate-tainted food.
METHODS: This prospective national cohort enrolled children and adolescents with
possible phthalate exposure between August 2012 and October 2016. These
participants received 3 times measurement on August 2012 to January 2013, July 2014
to February 2015, andMay 2016 to October 2016. The questionnaires, clinical
biochemical workup and renal injury biomarkers including urinary microalbumin and
N-acetyl-beta-D-glucosaminidase (NAG) were completed. Exposure was categorized
based on recommended tolerable daily intake level defined by the U.S. Environmental
Protection Agency (0.02 mg/kg/day) and the European Food Safety Authority (0.05
mg/kg/day).
RESULTS:Two-hundred fifty-three, 205, and 195 children and adolescents separately in
first, second and third enrollment were collected. Significant stepwise increases in urine
ACR from first enrollment corresponded to advancement from low exposure to high
exposure depending on phthalate-tainted food (P-trend< 0.001). In 2nd and 3rd
enrollment, no significant association between phthalate-tainted food exposure and urine
ACRwas found. Urine ACRwas positively associated with past DEHP-tainted food intake
after adjusting for other categorical covariates by generalized estimating equationmodels
(DDI> 0.5, ß = 0.106, p value = 0.034).MEPwas significantly associated withUACR and
MnBPwas significantly associated with urinary NAG.
CONCLUSIONS: Past DEHP exposure from phthalate-tainted foods intake may be
associated to elevate UACR in children and adolescents. The renal impact from
phthalate exposure should be paid attention and this unique group needs to follow
their long-term health consequences.
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INTRODUCTION: Acute Post-Infectious GlomeruloNephritis (PIGN) is a common
disorder in children. Low serumC3 level is a laboratory hallmark. Histologically, PIGN
appears with acute exudative proliferation of glomeruli on Light Microscopy (LM) and
C3 and Ig deposition on Immunofluorescence (IF). Most cases heal in few days or
weeks. In less cases, PIGN takes longer to resolve (atypical form) resulting in persistent
hematuria and proteinuria, or even progression to end-stage kidney disease. The aim of
our study is to evaluate the possible role of complement dysregulation in pathogenesis
of ‘atypical’ PIGN.
METHODS:We studied 201 PIGN children (121M, mean age: 5.6 yrs), from 2001 to
2017, retrospectively; in atypical cases kidney biopsy was performed. In selected
patients, molecular analysis of complement genes was achieved. In both typical and
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